Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) posted its earnings results on Thursday. Ironwood Pharmaceuticals had a net margin of 33.36% and a negative return on equity of 58.38%. Ironwood Pharmaceuticals Stock Up 1.4%IRWD stock traded up $0.06 during trading on Friday, reaching $4.32. Also, insider Ronald Silver sold 127,890 shares of Ironwood Pharmaceuticals stock in a transaction dated Tuesday, July 7th. Ironwood Pharmaceuticals Company Profile(Get Free Report)Ironwood Pharmaceuticals, Inc is a commercial‐stage biotechnology company focused on the discovery, development and commercialization of medicines for gastrointestinal (GI) disorders.